Article info
Short research report
Sweat chloride and immunoreactive trypsinogen in infants carrying two CFTR mutations and not affected by cystic fibrosis
- Correspondence to Dr Carlo Castellani, Cystic Fibrosis Center; Azienda Ospedaliera Universitaria Integrata, Piazzale Stefani 1, Verona 37126, Italy; carlo.castellani{at}ospedaleuniverona.it
Citation
Sweat chloride and immunoreactive trypsinogen in infants carrying two CFTR mutations and not affected by cystic fibrosis
Publication history
- Received July 21, 2015
- Revised December 2, 2015
- Accepted December 14, 2015
- First published January 11, 2016.
Online issue publication
February 17, 2018
Article Versions
- Previous version (24 July 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/